What are the first-line medications for essential tremor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Medications for Essential Tremor

Propranolol (80-240 mg/day) and primidone are the established first-line medications for essential tremor, with both agents demonstrating effectiveness in up to 70% of patients. 1, 2

Primary Treatment Options

Propranolol

  • Propranolol is the most established medication for essential tremor, having been used for over 40 years with demonstrated efficacy and is the only FDA-approved medication for this condition 1, 2
  • The recommended dosage range is 80-240 mg/day 1, 3
  • Propranolol improves tremor most notably in the upper extremities and enhances functional tasks like handwriting 4
  • Alternative beta-blockers can be substituted if propranolol causes adverse effects, including:
    • Nadolol (40-320 mg daily) 1
    • Metoprolol (25-100 mg extended release daily or twice daily) 1
    • Atenolol (limited evidence for moderate effect) 1
    • Timolol (20-30 mg/day) 1

Primidone

  • Primidone is equally effective as propranolol as first-line therapy, with efficacy in up to 70% of patients 1, 2
  • Can be used as monotherapy or in combination with propranolol if either agent alone provides inadequate tremor control 5, 6

When to Initiate Treatment

Medications should only be initiated when tremor symptoms interfere with function or quality of life 1. For patients whose tremor is disabling only during periods of stress and anxiety, propranolol or benzodiazepines can be used intermittently during those specific periods 5.

Important Contraindications and Precautions

Beta-Blocker Contraindications

Beta-blockers must be avoided in patients with:

  • Chronic obstructive pulmonary disease 1, 7
  • Bradycardia 1, 7
  • Congestive heart failure 1, 7

Common Adverse Effects

Beta-blockers may cause:

  • Fatigue and depression 1, 7
  • Dizziness and hypotension 1, 7
  • Exercise intolerance and sleep disorders 1
  • Cold extremities and bronchospasm 1
  • In elderly patients, excessive heart rate reduction may lead to serious adverse events 1

Treatment Algorithm

  1. Start with either propranolol (80-240 mg/day) OR primidone as monotherapy 1, 2

  2. If monotherapy fails, combine propranolol and primidone together 5, 6

  3. If propranolol causes adverse effects, switch to alternative beta-blockers (nadolol, metoprolol, or atenolol) 5, 6

  4. Second-line options if first-line agents fail:

    • Topiramate 2
    • Gabapentin (limited evidence for moderate efficacy) 1, 2
    • Benzodiazepines such as clonazepam or alprazolam, particularly for patients with associated anxiety 2, 5
  5. For medication-refractory tremor causing significant disability, consider surgical options including deep brain stimulation (DBS) or magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy 1, 8

Special Considerations

For patients with both essential tremor and hypertension, beta-blockers provide dual therapeutic benefits 1. Currently available medications improve tremor in approximately 50% of patients, and there is no cure or disease-modifying therapy available 5, 6.

Regular assessment of tremor severity and medication side effects is essential to optimize dosing and determine if alternative therapies are needed 1.

References

Guideline

Medications for Tremor Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Update on treatment of essential tremor.

Current treatment options in neurology, 2013

Guideline

Postural Tremor Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Generalized Tremor Causes and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Managing Essential Tremor.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.